The kinetics of hematopoietic stem cells were investigated in glucose-6-phosphate dehydrogenase (G-6-PD) heterozygous cats treated with dimethylbusulfan. Because of Xchromosome inactivation during embryogenesis, each somatic cell from these animals contains either maternal-or paternal-type G-6-PD. Therefore, all hematopoietic progenitor cells carry the G-6-PD phenotype of the most primitive cell (stem cell) from which they originate. For up to 6.5 years after dimethylbusulfan therapy, w e determined the percentages of erythroid and granulocyte/macrophage progenitor cells with each G-6-PD phenotype. Significant variations were seen in studies from five of six cats, showing that the population of stem cells contributing to hema-LOOD CELL production is maintained by the differ-B entiation and proliferation of progenitor cells derived from hematopoietic stem cells. The existence of stem cells has been established through experimental and clinical marrow transplantation. However, the identity ofthese earliest cells that contribute to hematopoiesis and their behavior in normal and in pathologic circumstances are not known.
B entiation and proliferation of progenitor cells derived from hematopoietic stem cells. The existence of stem cells has been established through experimental and clinical marrow transplantation. However, the identity ofthese earliest cells that contribute to hematopoiesis and their behavior in normal and in pathologic circumstances are not known.
In 1974, Morley and Blake' described a model of busulfan-induced marrow failure in mice. The mice received repeated doses of 20 mg/kg busulfan (LD,, = 30 mg/kg), became pancytopenic, and then recovered normal peripheral blood counts and marrow morphology. However, marrow from these mice contained low frequencies of the multilineage progenitor colony-forming unit-spleen (CFU-S),' proliferated poorly in long-term marrow culture,' and exhibited decreased proliferative potentials in transplantation ~t u d i e s .~.~ In addition, their CFU-S had abnormal (increased) cell cycle kinetic^.^ By 240 days, many busulfantreated mice developed aplastic anemia,' suggesting that the major clinical consequence of the drug occurred long after exposure. Taken together, these data provide evidence that marrow stem cells were damaged and/or depleted.
After high doses of busulfan (eg, 50 mg/kg), murine hematopoiesis is sufficiently impaired that donor marrow can permanently engrafL6 Similarly, busulfan and dimethylbusulfan (DMB) have been used as preparative regimens for canine' and human transplantation.8 For previous studies, we treated female Safari cats with DMB. These animals are the F1 offspring of Geoffroy (Leo-topoiesis was neither large nor constant. With mathematical analyses, w e estimated that the proliferative potential of residual stem cells was much less than that of normal stem cells reduced in number by autologous transplantation (Abkowitz et al, Proc Natl Acad Sci USA 87:9062, 1990). There was no evidence for the regeneration of a normal stem cell reserve over time; rather, damage was most pronounced years after dimethylbusulfan exposure. These data may help explain the high clinical incidence of aplastic anemia and myelodysplasia after alkylating agent therapies.
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pardus geofroyi) and domestic (Catusfelis) parents and are heterozygous for the X-chromosome-linked enzyme glucose-6-phosphate dehydrogenase (G-6-PD).9 Because of Xchromosome inactivation during embryogenesis, their somatic cells contain either Geoffroy-type or domestic-type Gd-PD, and not both. Our isoelectric focusing assay is sufficiently sensitive to determine the G-6-PD phenotypes of individual erythroid bursts (from burst-forming unit-erythroid [BFU-E]) or granulocyte-macrophage colonies (from CFU-granulocyte-macrophage [CFU-GM]) in methylcellulose cultures.' We repeatedly determined the Gd-PD phenotypes of BFU-E and CFU-GM for 6 months to 3 years after DMB.'~ For the studies in this report, the G-6-PD phenotypes of committed progenitors from these animals were determined for up to 6.5 years after DMB. Because each progenitor expresses a Gd-PD phenotype identical to the earliest cell (ie, the hematopoietic stem cell) from which it derives, this experimental approach provides an operational definition of "stem cell" and allows for studies of the behavior of cells within this compartment (Fig 1) . A mathematical model was used to estimate the numbers of active stem cell clones and their mean life span, ie, the length of time that progeny of an individual stem cell clone support hematopoiesis."
MATERIALS AND METHODS
Animal studies. Seven female Safari cats (nos. 6369 1, 63846, 63851, 64029, 64936, 65398, and 65558) received DMB (2,s-dimethanesulfonoxyhexane; 2 to 4 mg/kg intravenously [IV] at 2 to 5-week intervals for 3 doses). Before DMB, and in general each 2 to 5 weeks after therapy, marrow cells were cultured to determine the numbers of BFU-E and CFU-GM per lo5 mononuclear cells and for analysis of the G-6-PD phenotypes of individual colonies. Cell cycle kinetics of BFU-E and CFU-GM were assessed with 3H-thymidine suicide experiments. These methods and data from studies of the first six animals obtained during 6 months to 3 years (ie, 26 to 156 weeks) of observation were previously reported."
At 28 weeks, cat no. 6385 1 received additional DMB and died during the subsequent pancytopenia and is therefore excluded from these long-term analyses. Cat no. 64029 received additional DMB at week 96, and cat no. 94936 received additional DMB at weeks 50 and 108. The remaining four cats (nos. 63691, 63846, 65398, and 65558) received no additional therapy. 
Mathematical analyses.
A mathematical model to characterize stem cell behavior in female Safari cats has been previously described." This approach is feasible because (1) G-6-PD phenotype is a neutral marker that does not perturb the behavior of cells; (2) all cells are labeled; and (3) BFU-E and CFU-GM carry the G-6-PD phenotypes of the earliest cell from which they derive.
The model states that in each cat there is a pool of stem cells, a proportion p of which contain domestic-type G-6-PD. The proportion p is different in different cats. A subset of stem cells are active at any one time. The inactive cells constitute a reserve. An active stem cell "dies" when its corresponding clone is depleted, eg, through terminal differentiation. The time from activation to depletion is called the lifetime of the active stem cell. Lifetimes can vary and could reflect properties intrinsic to the stem cell, microenvironmental influences, and/or the proliferative demand in the host.
To simplify the mathematics, we assumed that N, the number of active stem cells in an individual cat, remained constant over the time period of the observations. Computer simulations showed that if one allows gradual changes in the value of N over time with the average value of N held constant (a so-called birth-and-death process), the conclusions from the autologous marrow transplantation data are unchanged." We let X ( t ) denote the number of domestictype G-6-PD clones active at time t. The X ( t ) takes values in (0, . . . , N } . We further assumed that active stem cells have independent lifetimes, and that the chance of death for each stem cell per time interval is constant, X. The mathematical implications ofthese assumptions are that stem cell lifetimes have an exponential distribution, with a standard deviation that is equal to the mean value. Because Gd-PD is a neutral marker,12 lifetime distributions are equivalent for stem cells with domestic-or Geoffroy-type G-6-PD. Also, when a stem cell clone is depleted, a randomly chosen stem cell from the reserve is activated.
In the biologic experiments we do not observe the process X ( t )
directly, but, rather, the numbers r, of progenitor cells with domestic-type G-6-PD obtained in samples of n, progenitors at sampling times t, (i = 1, . . . , m ) (Fig I) . The numbers Y, depend on the X-process only through the clones active at time t,. We assumed that, given the numbers X , = X(t,), the r, are independent random variables. A final assumption was that each active stem cell clone contributes roughly equivalently to the progenitor cell pool. Therefore, this pool has a proportion X , + N of progenitor cells with domestic-type G-6-PD, and the observed counts Y, are (conditionally) binomially distributed with the success probability X , + N.
Formal justification of these assumptions and discussion of constraints have been published previously."*12 Although the assumptions of this model may not be strictly met in cats treated with DMB (see Discussion), we applied this mathematical approach to studies in these animals. For each possible value of N (0 to 40 stem cell clones) and each possible mean life span L = 1 + X (0 to 300 weeks) we computed the likelihood, ie, the probability, that the observed sequence Y,, . . . , Y,,, would result if these were the true parameters. A topographical map of the likelihood minus its maximum was generated and most likely values for parameters Nand L were estimated for each cat. Details regarding the choice of contour lines are given in an Appendix. In studies of control cats with normal hematopoiesis, this approach predicted that many stem cell clones ( N > 40) each contributed to hematopoiesis for long periods of time ( L > 300 weeks)." In contrast, after autologous marrow transplantation, fewer stem cell clones support hematopoiesis ( N = 6 to 1 1) and L is finite (7 to 150 weeks).
RESULTS
Clinical data. Data from three representative animals are presented in Figs 2A, 3A, and 4A. At each determination, the percent of BFU-E with domestic-type G-6-PD was equivalent to the percent of CFU-GM with domestic-type G-6-PD, supporting the premise that the differentiation of stem cells and the commitment of their progeny to specific lineages are stochastic events. Therefore, results of BFU-E and CFU-GM studies were combined and the data are presented as the percentage of progenitors f SE with domestictype G-6-PD. Cumulative results are shown in Table 1 .
A significant change in the mean percentage of progenitors expressing domestic-type G-6-PD occurred immediately after initial drug exposure in four cats (nos. 6369 1, 63846, 64029, and 65398) (representative studies, Figs 2A and 3A). These altered ratios of Gd-PD phenotypes persisted throughout the time of observation (ie, up to 6.5 years) in cats no. 63691, 63846, and 64029 (Table 1) . We interpreted this to suggest a change in the clonal composition and number of cells in the stem cell reserve." If the residual stem cell clones continually supported hematopoiesis, the observed data from each cat should be similar to the post-DMB mean percentage of that animal's progenitors expressing domestic-type G-6-PD (ie, should be consistent with independent binomial observations about this parameter"). When this hypothesis was tested with xz analyses, P values were .002 (cat no. 63691), .7 (cat no. 63846), .8 and 8 X lo-' (cat no. 64029, after initial and final courses of DMB, respectively), .6 and 1 X (cat no. 64936), 3 X (cat no. 65398), and .04 (cat no. 65558) (Table 1) . Thus, the variation in the percentage of progenitors expressing domestic-type G-6-PD was significantly higher than a binomial distribution would allow after initial DMB exposure in three of six cats. In two more cats, the variation became significant after further DMB. Equally important, the variation was not sporadic or random, but, rather, was patterned over time (eg, Figs 2A, 3A , and 4A), suggesting the sequential activation and/or decline of stem cell clones.
Although cats became pancytopenic with each course of DMB, they quickly recovered normal counts and were hematologically normal at each observation time. Frequencies of marrow BFU-E and CFU-GM were also normal in all studies of all animals. For example, values were 52 k 4 and 39 4 per lo5 marrow mononuclear cells, respectively, for cat no. 64029; n = 21 experiments during weeks 204 through 296 after initial DMB (weeks 108 through 200 after final DMB). Similarly, thymidine suicide studies were repeatedly performed with progenitor cells from cats no. 64029 and 64936 and were normal. Specifically, the percentages of CFU-E, BFU-E, and CFU-GM in DNA synthesis were 56 f 5, 34 k 4, and 25 k 3 in five studies of cat no. 64029 during weeks 204 through 226 and were 65 2 5,35 k 4, and 32 k 3 in simultaneously studied control animals. Values for cat no. 64936 in three studies during weeks 150 through 161 after initial DMB (weeks 42 through 53 after final DMB) were 55% k 8%, 39% -t 5%, and 24% k 5% for CFU-E, BFU-E, and CFU-GM, respectively, and were 70% f 7%, 46% f 5%, and 23% ? 4%, respectively, in simultaneously studied control animals. Although hematologic parameters remained normal, two cats (nos. 63691 and 64936) with metastatic ovarian carcinomas were killed at weeks 292 and 16 1, respectively. Ovarian tumors are rare in cats and are thus a likely consequence of alkylating agent exposure in these animals. When our stochastic model was applied to data from each cat, log-likelihood surfaces were generated that had patterns distinctly different from those in normal cats and in cats after autologous transplantation. The analyses suggested that there were many active stem cell clones ( N = 12 to >40), yet each active for short periods oftime ( L = <2 to 18 weeks). Representative studies are in Figs 2B and 3B. Initial data from cat no. 63936 (obtained weeks 0 through 50 or 0 through 108) showed a pattern equivalent to that in normal cats ( N > 40, L > 100 weeks) (Fig 4B) . However, after the third course with the DMB, the data and analyses were similar to those of other animals ( N = 32, L < 2 weeks) (Fig 4C) . The most likely
Mathematical analyses.
values of N and L for each animal derived from data after the final course(s) of DMB are presented in Table 2 .
Because cats no. 64029 and 65398 were studied for long periods of time after final therapy with DMB, further analyses were feasible. Data from cat no. 65398 were separately analyzed with the mathematical model for years 0 through 3 after DMB and for years 3 through 6 (Fig 3C and D) . In this way, the late consequences of drug exposure could be analyzed separately from the earlier effects. Similarly, data from cat no. 64029 were separately analyzed for years 2 through 4 (0 through 2 after final DMB) and 4 through 6 (2 through 4 after final DMB) (Fig 2C and D) . These data suggest that the initial behavior of residual stem cells is normal (Fig 2C) or more similar to that in cats after autologous transplantation (Fig 3C) and that significant abnormalities did not develop until many years after drug exposures ( Figs  2D and 3D ). The patterns of log likelihood curves and specific estimates for N and L were not artifacts of more frequent sampling intervals over the last years of observation, as similar analyses that arbitrarily excluded three of each 
DISCUSSION
In a previous report, we showed that the G-6-PD phenotypes of BFU-E and CFU-GM can change after DMB exposure." We concluded that clonal evolution could reflect stem cell depletion and/or damage, and not just the dominance of a neoplastic clone. These animals were then studied for up to 6.5 years to determine the late hematologic consequence of that insult. Throughout this study, complete blood counts, marrow morphologies, the frequencies of BFU-E and CFU-GM in marrow aspirates, and the percentage of progenitor cells in DNA synthesis were normal. Thus, the behavior of committed progenitor cells and the subsequent events of hematopoiesis appeared normal.
We hypothesized that our studies of hematopoietic stem cells would yield one of three possible results. First, it was possible that over time a normal stem cell reserve would be regenerated by the self-renewal or the recovery of damaged hematopoietic cells. In this circumstance, the contributions of stem cells to hematopoiesis should be normal. Secondly, it was possible that residual stem cells, although decreased in number, functioned appropriately. Then stem cell kinetics would be similar to that after autologous transplanta- tion. Lastly, it was possible that DMB-induced damage was long lasting, permanently impairing the proliferative capacity of residual stem cells.
Four animals were studied repeatedly after initial courses of DMB. The fifth and sixth animals received repeated drug doses at 96 or 50 and 108 weeks. In four of these cats, the mean percent of progenitor expressing domestic-type G-6-PD changed immediately after drug exposure. When this new mean value persisted over 6 years (eg , Fig 2A) , the marrow reserve must have been reconstituted with a decreased number of hematopoietic cells (expressing an altered ratio of G-6-PD phenotypes).
More importantly, significant variation about the mean percent of progenitors with domestic-type G-6-PD was seen in five of six animals ( P values = .04 to 8 X lo-' after final DMB exposures). These data cannot be explained if a large or a stable population of stem cell clones supported hematopoiesis. The data therefore contrasted observations in normal (control) animals in which excess variability over the binomial distribution of the G-6-PD phenotype of progenitors about its mean value was not seen in longitudinal studies of five cats." Thus, there was no evidence for the recovery or the regeneration of a normal stem cell kinetics.
Because the variation in the percent of progenitors with domestic-type G-6-PD was significant and patterned over The standard error (SE) of the mean percentage of progenitors with domestic-type G-6-PD is computed under the assumption of independent samples from a binomial distribution. The extent of variation about the mean was tested with x2 analysis using a dispersion test,13 provided 24 different samples were analyzed during the time period. The P value represents the probability of seeing the observed variability under a binomial model, and a very small P value means that the variability is significantly larger than can be explained by a binomial distribution. After the final DMB therapy, variation in the percentage of progenitors about its mean value was significant in studies from five of six cats.
time (ie, not sporadic, not random), a stochastic process model, rather than a simple independent (binomial) model, was needed for further analysis. With this approach, we estimated that after final DMB exposures, from 12 to more than 40 stem cell clones were simultaneously active and that each stem cell had a short life span (<2 to 18 weeks). By extension, we predicted that the proliferative potential (number of progeny per stem cell life span) for each cell could be low and often extremely low (Table 2 ). For example, data from cat no. 64029 (Fig 2B) suggests that each stem cell supported less than 1/40 of hematopoiesis for less than 2 weeks (LIN < 0.05). This contrasted the proliferative potential of normal stem cells when reduced in number because of autologous transplantation" (eg, N = 7, L = 26 weeks, and individual cells might support 117 of hematopoiesis for 26 weeks; L / N = 3.7) ( Table 2 ). These data thus support the premise that the stem cells remaining after DMB exposure were permanently impaired.
As the model was developed to study the kinetics of normal stem cells, it involves assumptions that may not be strictly applicable to stem cells altered by DMB exposure. For example, the assumption that stem clones contribute equally to hematopoiesis may not be true, as the intensity of damage to individual stem cells could have a wide distribution. For this reason, the estimates of N and L should be taken as indicative of directions of departure from the analysis of normal cats and cats receiving transplants rather than as absolute determinations. The patterns of the log likelihood curves from all animals treated with DMB were remarkably consistent, and were very different from those obtained in studies of normal cats and studies of animals after autologous transplantation. This internal consistency helps validate the analytical approach.
Because of the large numbers of studies and long time period of observation, the data for cats no. 64029 and 65398 could be analyzed further and data from these animals that were generated over the first 2 to 3 years after their final DMB exposure were analyzed separately from that obtained over the subsequent 2 to 3 years. The analyses suggested that, late after DMB exposure, the behavior of hematopoietic stem cells was most abnormal. Both the variation in the percentage of progenitors with domestic-type G-6-PD and the estimates ofNand L (Figs 2C and D and 3C and D) raise the possibility that, at first, cells with minimal damage preferentially supported hematopoiesis, and that as these cells were exhausted through the terminal differentiation, more For personal use only. on August 30, 2017. by guest www.bloodjournal.org From damaged stem cells supported blood cell production. It is possible that, with further exhaustion of damaged cells, the residual stem cell reserve would be inadequate and aplastic anemia might result. These data are thus consistent with the clinical consequence of busulfan in mice' and rabbits.14 The increased and abnormal stem cell cycle kinetics might also contribute to the development of myelodysplasia, another late consequence of alkylating agent e x p~s u r e . '~ In this context, it is of note that two o f these six animals developed ovarian carcinoma. There are recursive methods for calculating the likelihood of this model. For standard models, when estimating two real-valued parameters, an approximate 95% confidence set is given by going down 3 units of log likelihood from the maximum." However, the present model is not standard, because the parameter N is integer-valued. To calibrate the likelihood surface we performed a parametric bootstrap." We repeatedly simulated the model on the computer using the parameter estimates resulting from the fit discussed in the section on Results. A simulation consisted of generating the X(t)-process in continuous time, generating the ObSeNations Yi at the same times ii and using the same numbers ni of analyzed colonies as in the observed process. For each simulation we estimated the parameters and compared the maximum likelihood in the simulation to the likelihood at the true simulated model. This yielded a distribution for the ratio of likelihoods (more precisely, for the natural logarithm of this ratio), which enabled us to decide how many units of log likelihood we need to go down from the maximum to have 95% confidence that we covered the true values. Figure 5 shows the results for cat-no. 65398. It is a histogram of the (bootstrap) distribution of the log likelihood ratio statistic, based on 20 bootstrap simulations (taking 33 hours on a dedicated Sun Sparcstation [Sun Microsystems, 
Department of Biostatistics. University of Wisconsin, Madison])
. This distribution hasa sample mean and sample vanance of 0.8, whereas the asymptotic approximation using Wilk's theorem would yield a mean an variance of 1. Thus. the bootstrap distribution is stochastically smaller than the asymptotic distribution, indicating that N can be estimated more precisely than in a standard situation. The cutoff value for a 95% interval would be 2.15 according to this simulation. The results for other cats were similar. Thus, our plots have contours at 0.5 (about the bootstrap median), I (the upper quartile). and 2 (about the 95% point) units of log likelihood below the maximum.
